Skip to content

Quick ratio at other companies

TEC
Bio-TechneTECH
3.2×+0.6×
Bruker logo
BrukerBRKR
0.7×0.0×
Illumina logo
IlluminaILMN
1.7×+0.3×
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
2.4×-1.8×
Revvity logo
RevvityRVTY
1.4×-1.6×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.4×-2.1×

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Calculated from 10x Genomics, Inc.’s reported figures.

Based on the most recent quarter.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s quick ratio?
10x Genomics, Inc. (TXG) reported quick ratio of 5.4× in Q1 2026.
How has 10x Genomics, Inc.'s quick ratio changed year-over-year?
10x Genomics, Inc.'s quick ratio increased by 15.9% year-over-year, from 4.7× to 5.4×.
What is the long-term trend for 10x Genomics, Inc.'s quick ratio?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s quick ratio has grown at a -8.3% compound annual growth rate (CAGR), from 6.3× to 4.1×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.